News
US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer: Basel Wednesday, April 30, 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback